Travere Therapeutics Inc (TVTX)
Cost of Revenue
$2.17M
Quarterly · Period ending: · USD
TVTX Cost of Revenue
Latest reported$2.17Mperiod ending
Latest reported$2.17Mperiod ending
TVTX Quarterly Cost of Revenue ($0.00 → $2.17M)
Quarterly cost of revenue
High-resolution chart · PNG
TVTX cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 2,174,000 | |
| 26,766,000 | |
| 2,553,000 | |
| 1,585,000 | |
| 1,521,000 | |
| 4,679,000 | |
| 2,553,000 | |
| 1,626,000 | |
| 12,406,000 | |
| 1,504,000 | |
| 16,416,000 | |
| 1,289,000 | |
| 1,452,000 | |
| 5,125,000 | |
| 1,728,000 | |
| 7,266,000 | |
| 2,051,000 | |
| 2,138,000 | |
| 1,896,000 | |
| 1,592,000 | |
| 1,651,000 | |
| 1,645,000 | |
| 2,072,000 | |
| 1,189,000 | |
| 1,494,000 | |
| 1,370,000 | |
| 7,015,000 | |
| 1,513,000 | |
| 979,000 | |
| 1,017,000 | |
| 1,603,000 | |
| 1,133,000 | |
| 1,178,000 | |
| 1,613,000 | |
| 1,174,000 | |
| 925,000 | |
| 797,000 | |
| 709,000 | |
| 1,203,000 | |
| 1,573,000 | |
| 1,021,000 | |
| 757,000 | |
| 761,000 | |
| 513,000 | |
| 637,000 | |
| 274,447 | |
| 337,708 | |
| 197,411 | |
| 1,207,395 | |
| 900 | |
| 100,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |